Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary L Disis

Showing results (31-40 of 189) with videos related to

Pageof 19
Sort By:
Cancer Immunology, Immunotherapy : CII|May 14, 2005
Adoptive T cell therapy of solid cancersKeith L Knutson, Wolfgang Wagner, Mary L Disis
JAMA Oncology|June 30, 2016
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic ReviewSasha E Stanton, Sylvia Adams, Mary L Disis
Vaccine|August 5, 2015
Current methods of epitope identification for cancer vaccine designGregory A Cherryholmes, Sasha E Stanton, Mary L Disis
Breast Disease|February 3, 2005
Peptide-based vaccines in breast cancerMary L Disis, Lupe G Salazar, Keith L Knutson
Cancer Prevention Research (Philadelphia, Pa.)|January 10, 2015
The antigenic repertoire of premalignant and high-risk lesionsJuan Pablo Marquez, Sasha E Stanton, Mary L Disis
Oncoimmunology|May 6, 2015
Th1 epitope selection for clinically effective cancer vaccinesMary L Disis, William C Watt, Denise L Cecil
Advances in Experimental Medicine and Biology|November 13, 2019
Immuno-Oncology in the Era of Personalized MedicineWilliam R Gwin, Mary L Disis, Erika Ruiz-Garcia
Breast Cancer (Dove Medical Press)|December 25, 2013
Progress in the development of a therapeutic vaccine for breast cancerAndrew L Coveler, Nicole E Bates, Mary L Disis
Seminars in Immunopathology|December 16, 2016
Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancerWilliam C Watt, Denise L Cecil, Mary L Disis
Cancer Immunology, Immunotherapy : CII|July 5, 2006
CD4 regulatory T cells in human cancer pathogenesisKeith L Knutson, Mary L Disis, Lupe G Salazar
Pageof 19

Showing results (31-40 of 189) with videos related to

Sort By:
Pageof 19
Cancer Immunology, Immunotherapy : CII|May 14, 2005
Adoptive T cell therapy of solid cancersKeith L Knutson, Wolfgang Wagner, Mary L Disis
JAMA Oncology|June 30, 2016
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic ReviewSasha E Stanton, Sylvia Adams, Mary L Disis
Vaccine|August 5, 2015
Current methods of epitope identification for cancer vaccine designGregory A Cherryholmes, Sasha E Stanton, Mary L Disis
Breast Disease|February 3, 2005
Peptide-based vaccines in breast cancerMary L Disis, Lupe G Salazar, Keith L Knutson
Cancer Prevention Research (Philadelphia, Pa.)|January 10, 2015
The antigenic repertoire of premalignant and high-risk lesionsJuan Pablo Marquez, Sasha E Stanton, Mary L Disis
Oncoimmunology|May 6, 2015
Th1 epitope selection for clinically effective cancer vaccinesMary L Disis, William C Watt, Denise L Cecil
Advances in Experimental Medicine and Biology|November 13, 2019
Immuno-Oncology in the Era of Personalized MedicineWilliam R Gwin, Mary L Disis, Erika Ruiz-Garcia
Breast Cancer (Dove Medical Press)|December 25, 2013
Progress in the development of a therapeutic vaccine for breast cancerAndrew L Coveler, Nicole E Bates, Mary L Disis
Seminars in Immunopathology|December 16, 2016
Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancerWilliam C Watt, Denise L Cecil, Mary L Disis
Cancer Immunology, Immunotherapy : CII|July 5, 2006
CD4 regulatory T cells in human cancer pathogenesisKeith L Knutson, Mary L Disis, Lupe G Salazar
Pageof 19